This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PROC Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PROC WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~52.1 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Glycosylation and cleavage | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The M01742 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HepG2 cell lysate (catalog M01742) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M01742; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PROC has a 52.1 kDa precursor backbone; glycosylation can shift migration upward, while precursor and heavy/light-chain cleavage change the band pattern.
| Band near 52.1 kDa | full-length precursor backbone near its predicted mass |
| Higher or diffuse band | glycosylated protein C, with variable occupancy including partial glycosylation at Asn371 |
| Lower band than the precursor | processed protein C after precursor or chain cleavage |
| Several bands at different positions | processing, glycoforms, or isoforms 1 and 2 may contribute |
| Little or no band in whole-cell lysate | protein C is secreted |
| 52.1 kDa predicted precursor mass | provides the unmodified full-length reference size |
| N-glycosylation at Asn139, Asn290, and Asn355 | adds carbohydrate and can raise apparent size |
| Partial N-glycosylation at Asn371 | can create variable migration or a broader band |
| O-glycosylation at Thr19 | can modify the propeptide before its removal |
| Signal peptide 1–18 and propeptide 19–42 cleavage | makes the mature protein smaller than the full-length precursor |
| Disulfide-linked heavy and light chains | remain linked without reduction but separate upon reduction |
| Isoforms 1 and 2 | may differ in size; individual masses are unavailable |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | protein C is secreted | check conditioned medium or a secretion-enriched sample |
| Band higher than expected | N-linked glycans increase apparent size | compare with a deglycosylated aliquot |
| Band lower than expected | signal and propeptide removal or chain processing | compare reducing and nonreducing lanes |
| Broad smear instead of sharp band | heterogeneous glycosylation, including partial occupancy at Asn371 | compare with a deglycosylated aliquot |
| Multiple bands | processing, glycoforms, or isoforms 1 and 2 | compare reduction and deglycosylation conditions |
| Fragments below expected size | cleavage into heavy and light chains | compare reducing and nonreducing lanes |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for PROC, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-Protein C antibodies are listed for Western blot: M01742, PA1682, and A01742. Each has a WB image. The supplied details identify HepG2 cell lysate for M01742; JURKAT, CEM, SMMC, and HELA cell lysates for PA1682; and rat and mouse liver tissue lysates for A01742.
Which to pick: Match the WB example to your sample context: M01742 for HepG2 cells, PA1682 for the listed cell lysates, or A01742 for rat or mouse liver tissue.